The inspiring story of Emma Betts premieres on Australian Story
16 April 2018
Emma Betts was only 22 years old when she learned that she had stage 4 melanoma. Emma shared her story with many by documenting her experience with melanoma on her blog Dear Melanoma. She sadly passed away at the age of 25 in April, 2017.
Australian Story's 'Dear Emma' is a tribute to the life and times of a young woman determined to raise awareness about melanoma. A true tear-jerker, the segment will explore how Emma and her husband Serge dealt with her heartbreak and how her parents Tamra and Leon, are continuing Emma’s legacy of encouraging others to contribute to life-saving research.
Although Emma was not a patient of Melanoma Institute Australia, she cared very deeply about people with melanoma and people at risk of melanoma around the country. She did everything she could to get the word out and raised a lot of funds for research at MIA - which reveals the complexity of the drivers of melanoma in younger people. It's not only about sun damage.
We're committed to weaving Emma's loving legacy into the work we'll be undertaking to draw attention to melanoma in young Australians and the research, treatment and education strategies we need to stop losing them to this disease.
Emma Betts started the national conversation about melanoma that Australia has to have. To continue Emma’s legacy, we need to keep that conversation going.
The World Health Organisation (WHO) is releasing the 4th edition of Classification of Skin Tumours.
Former Executive Director of Melanoma Institute Australia Professor John Thompson awarded the prestigious 2018 RPA Foundation Research Medal.
Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for pembrolizumab.
The World Congress on Cancers of the Skin 2018 has featured many minds from MIA sharing their expertise and wealth of knowledge with over 1000 attendees from around the world.
Melanoma Institute Australia is delighted to announce the appointment of Matthew Browne as Chief Executive Officer (CEO).
It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’.
A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.
Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.
'Dear Emma' - a tribute to the life and times of a young woman determined to raise awareness about melanoma.
Carole Renouf, CEO for MIA thanks Toyota for helping fuel ongoing melanoma research.
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark 'Bod' Boddison.